| Literature DB >> 26568869 |
Tomasz Golabek1, Tomasz Wiatr1, Mikolaj Przydacz1, Jakub Bukowczan2, Przemyslaw Dudek1, Robert Sobczynski3, Katarzyna Golabek4, Piotr L Chłosta1.
Abstract
INTRODUCTION: Creation of a watertight vesicourethral anastomosis is a challenging and time-consuming procedure. In an attempt to simplify this critical step of radical prostatectomy we have developed a laparoscopic running single suture technique and presented preliminary results previously. Here we report our two-year experience with the Chlosta's single running suture technique.Entities:
Keywords: laparoscopic radical prostatectomy; surgical technique; vesicourethral anastomosis
Year: 2015 PMID: 26568869 PMCID: PMC4643710 DOI: 10.5173/ceju.2015.617
Source DB: PubMed Journal: Cent European J Urol ISSN: 2080-4806
Figure 1Intraoperative photograph illustrating step one of the Chlosta's technique for performing the single running suture vesicourethral anastomosis. The stitch is placed first at the 5-o'clock position on the posterolateral aspect of the bladder outside-in and then through the urethra at the same location inside-out.
Figure 2Oblique view illustrating step one of the Chlosta's technique for performing the single running suture vesicourethral anastomosis.
Figure 3Oblique view illustrating step two of the Chlosta's technique for performing the single running suture vesicourethral anastomosis. Proceeding counterclockwise, running suture is always driven full-thickness. The suture is placed 4-6 times through both the bladder neck and the urethra until its two ends meet at the 5-o'clock position.
Figure 4Oblique view illustrating the final step of the Chlosta's technique for performing the single running suture vesicourethral anastomosis. The both ends of the suture are tied outside the bladder.
Patient demographics
| Variable | Value |
|---|---|
| Mean Age (±SD), years | 63.00 (±6.54) |
| Mean PSA (±SD), ng/ml | 10.00 (±8.19) |
| Median Preoperative Gleason Score | 6 |
| Preoperative Gleason Score, (n)% | |
| 4 | (1) 1.7 |
| 5 | (3) 5 |
| 6 | (32) 53.4 |
| 7 | (20) 33.4 |
| 8 | (2) 3.3 |
| 9 | (2) 3.3 |
| 10 | 0 |
SD – standard deviation; n – number of cases
Intra- and perioperative data
| Variable | Value |
|---|---|
| Surgical characteristics | |
| Mean prostate weight (±SD), g | 55.97 (±20.43) |
| Mean anastomosis time (±SD), min | 10.20 (±2.81) |
| Mean operative time (±SD), min | 148.00 (±40.37) |
| Mean blood loss (±SD), ml | 167.03 (±61.19) |
| Transfusion rate, % | 0 |
| Conversion rate, % | 0 |
| Mean drainage time, days | 2.75 (±0.7) |
| Mean catheterisation time (±SD), days | 17.68 (±4.20) |
| Mean LOS (±SD), days | 6.6 (±0.6) |
| Urinary leak | |
| Intraoperative anastomotic leak (n),% | (2) 3.3 |
| Clinically significant anastomotic leak (n), % | 0 |
| Perioperative complications | |
| Bladder neck contracture (n), % | (1) 1.7 |
| Minor (n), % | (1) 1.7 |
| Intermediate (n), % | (1) 1.7 |
| Major (n), % | 0 |
SD – standard deviation; number of cases; LOS – length of hospital stay; Clinically significant anastomotic leak = leaks that necessitated interventional drainage, or those that resulted in ileus necessitating readmission and intravenous fluids, or those that were associated with fever and signs of sepsis necessitating antibiotic therapy or drainage; 90-day perioperative complications: minor (no hospital admission required), intermediate (required reoperation, conversion, or admission to an intensive care unit for less than 24 hours), and major (life-threatening or required hospital stay of more than 24 hours in an intensive care unit, and reoperation)
Oncologic and urinary continence outcomes
| Variable | Value | |
|---|---|---|
| pT2a (n), % | (4) 6.7 | |
| pT2b (n), % | (1) 1.7 | |
| pT2c (n), % | (22) 36.7 | |
| pT3a (n), % | (28) 46.7 | |
| pT3b (n), % | (5) 8.2 | |
| pT4a (n), % | 0 | |
| Median Postoperative Gleason Score | 7 | |
| Postoperative Gleason Score, (n),% | ||
| 4 | 0 | |
| 5 | 0 | |
| 6 | (18) 30.0 | |
| 7 | (34) 56.6 | |
| 8 | (4) 6.7 | |
| 9 | (4) 6.7 | |
| 10 | 0 | |
| Return of continence | ||
| RXT+ | RXT- | |
| 3 months (n), % | (44/60) 73.3 | (43/56) 76.8 |
| 6 months (n), % | (51/60) 85.0 | (50/56) 89.3 |
| 12 months (n), % | (58/60) 96.7 | (54/56) 96.4 |
| 18 months (n), % | (57/60) 95 | (54/56) 96.4 |
n – number of cases; RXT+ – continence rates of all patients including those who underwent adjuvant radiotherapy; RXT- – continence rates of patients who did not receive adjuvant radiotherapy